Aspirin/lisinopril/lovastatinAlternative Names: CardiaPill; CP-101; polypill-CardioPharma
Latest Information Update: 20 Dec 2015
At a glance
- Originator CardioPharma
- Class Carboxylic acids; Esters; Lactones; Salicylic acids; Small molecules
- Mechanism of Action ACE inhibitors; Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 modulators; HMG-CoA reductase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Cardiovascular disorders